QQQSvsBBCETF Comparison
Invesco NASDAQ Future Gen 200 ETF (QQQS) belongs to the US Small Cap segment. Virtus LifeSci Biotech Clinical Trials ETF (BBC) is part of the Tomorrow's Treatments segment. QQQS's top 3 sector exposures are Healthcare, Technology and Consumer Cyclicals. In contrast, BBC's top sector exposures are Healthcare. QQQS is less expensive with a Total Expense Ratio (TER) of 0.2%, versus 0.65% for BBC. QQQS is up 24.94% year-to-date (YTD) with +$11M in YTD flows. BBC performs worse with 24.86% YTD performance, and +$5M in YTD flows. Run a side-by-side ETF comparison of QQQS and BBC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
QQQS vs BBC performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | QQQS BBC | -5.07%-9.12% | +2.54%+12.12% | +24.94%+24.86% | +37.98%+102.94% | +83.83%+141.05% | n/a+3.72% |
| Flows | QQQS BBC | +$4M- | +$5M+$83K | +$11M+$5M | +$13M+$12M | +$14M+$16M | -+$8M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | QQQS BBC | +21.47%+33.55% | +26.98%+36.27% | +29.01%+37.28% | n/a+39.65% |
| Max drawdown | QQQS BBC | -7.41%-13.66% | -13.66%-14.64% | -34.40%-54.25% | n/a-70.43% |
| Max drawdown duration | QQQS BBC | 41d28d | 81d60d | 253d340d | n/a1666d |
QQQS | BBC | |
Last sale 9/17/2026 at 2:56 PM | $43.38 | $49.40 |
| Previous close 09/16/2026 | $42.54 | $48.19 |
| Consolidated volume 09/16/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
QQQS | BBC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
QQQS | BBC | |
|---|---|---|
| Last price | $43.38 | $49.40 |
| 1D performance | +1.97% | +2.50% |
| AuM | $25.93 M | $45.89 M |
| E/R | 0.2% | 0.65% |
QQQS | BBC | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Invesco | VIRTUS Investment Partners |
| Benchmark | Nasdaq Innovators Completion Cap Index | LifeSci Biotechnology Clinical Trials Index |
| N° of holdings | 200 | 127 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 13, 2022 | December 16, 2014 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
